TORASEMIDE SAFETY IN COMPLEX THERAPY OF CHRONIC CARDIAC INSUFFICIENCY: RESULTS OF RANDOMIZED CROSS STUDY
In therapy of patients with chronic cardiac insufficiency we must use obligatory drugs as angiotensin-converting enzyme inhibitors (ACE inhibitors)/sartans, β-antagonists and mineral- corticoid receptor antagonists (MCRA). As is known, ACE inhibitors and MCRA can lead to potassium retention in the h...
Main Author: | E. E. AVERIN |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2016-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1367 |
Similar Items
-
EFFECT OF FUROSEMIDE AND TORASEMIDE ON HEART RATE VARIABILITY AND VENTRICULAR RHYTHM DISORDERS IN PATIENTS WITH CHRONIC HEART FAILURE COMPLICATING ISCHEMIC HEART DISEASE: COMPARATIVE NONRANDOMIZED STUDY
by: H. H. Shugushev, et al.
Published: (2016-01-01) -
In dogs with congestive heart failure, is torasemide superior to furosemide as a first line diuretic treatment?
by: Leo Packham
Published: (2020-11-01) -
The potential toxicity of loop diuretics in patients with cardiovascular complications
by: Grzegorz Liczner, et al.
Published: (2018-12-01) -
Pathogenetic treatment of chronic heart failure: the role of torasemide
by: N B Perepech
Published: (2015-09-01) -
Loop diuretics in the treatment of edema: torasemide potentials
by: V V Fomin, et al.
Published: (2008-06-01)